Tiffany Tsui, PhD

Director, Program and Alliance Management at Envisagenics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
New York City Metropolitan Area

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Fundamental of the Bioscience Industry
    Center for Biotechnology
    May, 2013
    - Nov, 2024

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Director, Program and Alliance Management
      • Mar 2020 - Present

    • Director of Business Development
      • Nov 2018 - Mar 2020

    • Director of Operations & Business Development
      • Jul 2017 - Oct 2018

    • Manager, Operations & Business Development
      • Feb 2017 - Jun 2017

    • Technology Commercialization Fellow
      • Sep 2015 - Feb 2017

    • United States
    • Higher Education
    • 700 & Above Employee
    • Doctoral Candidate
      • Sep 2009 - Aug 2015

      To determine the effect of cancer-associated somatic mutations on activity and auto-regulation of non-receptor tyrosine kinases To determine the effect of cancer-associated somatic mutations on activity and auto-regulation of non-receptor tyrosine kinases

  • Fundamentals of the Bioscience Industry Program
    • Center for Biotechnology, Stony Brook, NY
    • Lead Consultant, Regulatory Affairs and Financial Analysis
      • Jan 2013 - May 2013

      Worked in a team to prepare a comprehensive report on the development of a technology licensing program on novel polymeric prosthetic heart valves for the treatment of valvular heart disease. Work included research and analysis on valuation, licensing strategies, product development, market and market positioning, regulatory pathways to commercialization, and final recommendations on the technology for the Office of Technology Licensing and Industry Relations at Stony Brook University. Worked in a team to prepare a comprehensive report on the development of a technology licensing program on novel polymeric prosthetic heart valves for the treatment of valvular heart disease. Work included research and analysis on valuation, licensing strategies, product development, market and market positioning, regulatory pathways to commercialization, and final recommendations on the technology for the Office of Technology Licensing and Industry Relations at Stony Brook University.

    • United States
    • Pharmaceutical Manufacturing
    • 400 - 500 Employee
    • Research Associate I
      • Jun 2007 - Jul 2009

      Generated profiles of various drugs as part of the CNSProfile™, a platform developed by the company, to determine the effects of compounds on disease-relevant intracellular phosphoproteins. Generated profiles of various drugs as part of the CNSProfile™, a platform developed by the company, to determine the effects of compounds on disease-relevant intracellular phosphoproteins.

Education

  • Stony Brook University
    Doctor of Philosophy (PhD), Molecular and Cellular Pharmacology
    2009 - 2015
  • University of Rochester
    BS, Biochemistry
    2003 - 2007

Community

You need to have a working account to view this content. Click here to join now